Showing results (701-710 of 813) with videos related to

Sort By:
Pageof 82
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2004
Characterization of mutator phenotype in familial colorectal cancer patients not fulfilling amsterdam criteriaJin C Kim, Kang H Lee, In H Ka, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 20, 2022
[Effect of genetic polymorphism of TPMT and NUDT15 on the tolerance of 6-mercaptopurine therapy in adult acute lymphoblastic leukemia]Q S Hao, Z Wang, Q Y Fang, et al.
Plos One|November 25, 2011
Clinical and genetic determinants of warfarin pharmacokinetics and pharmacodynamics during treatment initiationInna Y Gong, Ute I Schwarz, Natalie Crown, et al.
Clinical Pharmacology and Therapeutics|July 3, 2009
Hydrochlorothiazide and atenolol combination antihypertensive therapy: effects of drug initiation orderJ A Johnson, Y Gong, K R Bailey, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|July 2, 2024
[Molecular characteristics and drug susceptibility analysis of Streptococcus agalactiae from respiratory specimen sources]X Han, X Y Gong, B B Miao, et al.
Leukemia & Lymphoma|November 3, 2025
Reporting and enrollment disparities in hematologic malignancy trials between 2000-2023Inna Y Gong, Bahar Rafinejad-Farahani, Haris Majeed, et al.
European Journal of Neurology|July 31, 2007
Extracellular signal-regulated protein kinase in human intractable epilepsyZ-Q Xi, X-F Wang, R-Q He, et al.
Thrombosis Research|September 20, 2001
Pharmacological characterization of a novel factor Xa inhibitor, FXV673V Chu, K Brown, D Colussi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 5, 2025
Circulating tumor DNA clearance as a predictive biomarker of pathologic complete response in patients with solid tumors treated with neoadjuvant immune checkpoint inhibitors: a systematic review and meta-analysisC Valenza, E F Saldanha, Y Gong, et al.
Breast Cancer Research and Treatment|April 13, 2013
CYP3A4 and seasonal variation in vitamin D status in addition to CYP2D6 contribute to therapeutic endoxifen level during tamoxifen therapyWendy A Teft, Inna Y Gong, Brian Dingle, et al.
Pageof 82